BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3234483)

  • 1. Serotonergic regulation of noradrenergic coerulean neurons: electrophysiological evidence for the involvement of 5-HT2 receptors.
    Gorea E; Adrien J
    Eur J Pharmacol; 1988 Sep; 154(3):285-91. PubMed ID: 3234483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of noradrenergic coerulean neuronal firing mediated by 5-HT2 receptors: involvement of the prepositus hypoglossal nucleus.
    Gorea E; Davenne D; Lanfumey L; Chastanet M; Adrien J
    Neuropharmacology; 1991 Dec; 30(12A):1309-18. PubMed ID: 1787885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 5-hydroxytryptamine2 agonist augments gamma-aminobutyric acid and excitatory amino acid inputs to noradrenergic locus coeruleus neurons.
    Chiang C; Aston-Jones G
    Neuroscience; 1993 May; 54(2):409-20. PubMed ID: 8101639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
    Eison AS; Eison MS; Yocca FD; Gianutsos G
    Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M; Lyon RA; Davis KH; Glennon RA
    Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo.
    Done CJ; Sharp T
    Br J Pharmacol; 1992 Sep; 107(1):240-5. PubMed ID: 1422575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute administration of the antidepressant trazodone increases noradrenergic locus coeruleus neuronal firing in rats.
    VanderMaelen CP; Braselton JP
    Arch Int Pharmacodyn Ther; 1990; 308():13-20. PubMed ID: 2099132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenethylamine hallucinogens in the locus coeruleus: potency of action correlates with rank order of 5-HT2 binding affinity.
    Rasmussen K; Glennon RA; Aghajanian GK
    Eur J Pharmacol; 1986 Dec; 132(1):79-82. PubMed ID: 3816969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT2 receptors, roles and regulation.
    Leysen JE; Pauwels PJ
    Ann N Y Acad Sci; 1990; 600():183-91; discussion 192-3. PubMed ID: 2252309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of vinpocetine on noradrenergic neurons in rat locus coeruleus.
    Gaál L; Molnár P
    Eur J Pharmacol; 1990 Oct; 187(3):537-9. PubMed ID: 2073927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noradrenergic denervation alters serotonin2-mediated behavior but not serotonin2 receptor number in rats: modulatory role of beta adrenergic receptors.
    Eison AS; Yocca FD; Gianutsos G
    J Pharmacol Exp Ther; 1988 Aug; 246(2):571-7. PubMed ID: 2900327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potency of antipsychotics in reversing the effects of a hallucinogenic drug on locus coeruleus neurons correlates with 5-HT2 binding affinity.
    Rasmussen K; Aghajanian GK
    Neuropsychopharmacology; 1988 May; 1(2):101-7. PubMed ID: 2908015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.
    Branchek T; Adham N; Macchi M; Kao HT; Hartig PR
    Mol Pharmacol; 1990 Nov; 38(5):604-9. PubMed ID: 2233697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique modulation of central 5-HT2 receptor binding sites and 5-HT2 receptor-mediated behavior by continuous gepirone treatment.
    Yocca FD; Eison AS; Hyslop DK; Ryan E; Taylor DP; Gianutsos G
    Life Sci; 1991; 49(24):1777-85. PubMed ID: 1682780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.
    Glennon RA; Young R; Rosecrans JA
    Eur J Pharmacol; 1983 Jul; 91(2-3):189-96. PubMed ID: 6617740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further studies of serotonergic activity in the regulation of the cold stimulated thyrotropin secretion in male rats.
    Männistö PT; Tuominen RK
    Pharmacol Toxicol; 1988 Aug; 63(2):65-9. PubMed ID: 3186622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo comparison of two 5-HT1A receptors agonists alnespirone (S-20499) and buspirone on locus coeruleus neuronal activity.
    Astier B; Lambás Señas L; Soulière F; Schmitt P; Urbain N; Rentero N; Bert L; Denoroy L; Renaud B; Lesourd M; Muñoz C; Chouvet G
    Eur J Pharmacol; 2003 Jan; 459(1):17-26. PubMed ID: 12505530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin-norepinephrine interactions: a voltammetric study on the effect of serotonin receptor stimulation followed in the N. raphe dorsalis and the Locus coeruleus of the rat.
    Clement HW; Gemsa D; Wesemann W
    J Neural Transm Gen Sect; 1992; 88(1):11-23. PubMed ID: 1374260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonergic modulation of footshock induced aggression in paired rats.
    Datla KP; Mitra SK; Bhattacharya SK
    Indian J Exp Biol; 1991 Jul; 29(7):631-5. PubMed ID: 1839019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system.
    Haddjeri N; de Montigny C; Blier P
    Br J Pharmacol; 1997 Mar; 120(5):865-75. PubMed ID: 9138693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.